Directors and Officers
Directors (as of June 26, 2026)
-

President and Representative Director CEO
Terukazu Kato
brief personal recordPresident and Representative Director CEO
Terukazu KatoAugust 26, 1963

President and Representative Director CEO
Terukazu KatoAugust 26, 1963
1986 Joined the Company
2001 President and Representative Director of TSUMURA USA, INC.
President and Representative Director of Pacific Marketing Alliance, Inc.2006 Head of Public Relations Department, TSUMURA & CO.
2007 General Manager, Head of Corporate Communications Department, TSUMURA & CO.
2011 Director and Executive Officer, Head of Corporate Communications of the Company
2012 President and Representative Director of the Company
2015 President and Representative Director and President and Executive Officer, TSUMURA & CO.
2019 President and Representative Director CEO of the Company (incumbent)
Year of assumption of the post of Director: 2011
Number of shares in the Company held:49,300 shares【as of March 31, 2026】 -

Representative Director COO
Kei Sugii
brief personal recordRepresentative Director COO
Kei SugiiDecember 16, 1969

Representative Director COO
Kei SugiiDecember 16, 1969
1994 Joined Mitsubishi Petrochemical Engineering Corporation (currently Mitsubishi Chemical Engineering Corporation)
2006 Joined Accenture Japan Ltd.
2009 Joined the Company
2013 Head of Logistics Planning Department
2016 Head of SCM Planning Department
2017 General Manager of the Company, CEO of SHENZHEN TSUMURA MEDICINE CO., LTD.
2018 General Manager of the Company, Chairman and CEO of SHENZHEN TSUMURA MEDICINE CO., LTD.
2020 Executive Officer, Production Division General Manager of the Company
2022 Director Co-COO
2026 Representative Director COO and President, Prescription Pharmaceuticals Company, TSUMURA & CO. (incumbent)
Year of assumption of the post of Director: 2022
Number of shares in the Company held:10,900 shares【as of March 31, 2026】 -

Director CTO
Akihito Konda
brief personal recordDirector CTO
Akihito KondaAugust 6, 1969

Director CTO
Akihito KondaAugust 6, 1969
1992 Joined the Company
2010 General Manager of First Hospital Sales Department, Tokyo Regional Branch, Sales & Marketing Division, TSUMURA & CO.
2013 General Manager of Therapeutic Area Promotion Department, Kampo Scientific Strategies Division, TSUMURA & CO.
2017 General Manager, Head of Kampo Scientific Strategies Division, TSUMURA & CO.
2020 Executive Officer, Head of Kampo Research & Development Division, Supervising the International Pharmaceutical Research & Development Division and Kampo Scientific Strategies Division, TSUMURA & CO.
2024 Executive Officer, Head of Research & Development Division, Supervising the International Pharmaceutical Research & Development Division and Marketing Division, TSUMURA & CO.
2025 CTO and Head of Research & Development Division, TSUMURA & CO.
2026 Director CTO and Head of Research & Development Division, Research & Development Unit, Prescription Pharmaceuticals Company, TSUMURA & CO. (incumbent)
Year of assumption of the post of Director: 2026
Number of shares in the Company held:6,200 shares【as of March 31, 2026】 -

Director (Outside Director)
Tadashi Okada
brief personal recordDirector (Outside Director)
Tadashi OkadaMay 1, 1956

Director (Outside Director)
Tadashi OkadaMay 1, 1956
1979 Joined Komatsu Ltd.
2003 Vice President of Komatsu (China) Ltd.
2006 General Manager of Corporate Communications Department, Komatsu Ltd.
2007 Executive Officer, General Manager of Corporate Communications Department, Komatsu Ltd.
2008 Executive Officer, General Manager of Corporate Planning Division, Komatsu Ltd.
2009 Executive Officer, Vice President of Industrial Machinery General Headquarters, Komatsu Ltd.
2011 Senior Executive Officer, President of Industrial Machinery Division, Komatsu Ltd.
2014 Senior Executive Officer, Supervising Corporate Communications, CSR, General Affairs, and Compliance of Komatsu Ltd.
2017 Representative Director and Chairman of QUALICA Inc.
2020 Outside Director of TSUMURA & CO. (incumbent)
Year of assumption of the post of Director: 2020
Number of shares in the Company held:1,500 shares【as of March 31, 2026】 -

Director (Outside Director)
Mariko Eguchi
brief personal recordDirector (Outside Director)
Mariko EguchiMarch 13, 1966

Director (Outside Director)
Mariko EguchiMarch 13, 1966
1988 Joined The Mitsubishi Bank, Limited (currently MUFG Bank, Ltd.)
1999 Joined Nikko Salomon Smith Barney Limited (currently Citigroup Global Markets Japan Inc.) Vice President, Investment Banking Division
2006 Joined UBS Securities Japan Co., Ltd., Director of Investment Banking
2008 Director, Public Relations Division (Corporate Communications & Branding), UBS Group
2019 Joined LaSalle Investment Management, Inc. Director, Asia Pacific Public Relations Division
2020 Joined Aflac Life Insurance Japan Ltd. Executive Officer, Public Relations Department, Office for the Promotion of Social and Public Activities
2024 Advisor, Aflac Life Insurance Japan Ltd. (incumbent)
2025 Outside Director, SIGMAXYZ Holdings Inc. (incumbent)
2025 Outside Director of TSUMURA & CO. (incumbent)
Year of assumption of the post of Director: 2025
Number of shares in the Company held:200 shares【as of March 31, 2026】 -

Director (Outside Director)
Junichiro Nakatsuka
brief personal recordDirector (Outside Director)
Junichiro NakatsukaNovember 9, 1963

Director (Outside Director)
Junichiro NakatsukaNovember 9, 1963
1986 Joined Mitsubishi Corporation
2012 Sales General Manager, Power Systems Export Unit, Mitsubishi Corporation
2014 General Manager, Power Systems International Department, Mitsubishi Corporation
2017 President, Mitsubishi Corporation (Shanghai) Ltd.
2021 Chief Representative for China, President, Mitsubishi Corporation China Co., Ltd.
2023 President & CEO, Mitsubishi Corporation Machinery, Inc.
2025 Director, JEE POWER Co., Ltd.(incumbent)
2026 Outside Director of TSUMURA & CO. (incumbent)
Year of assumption of the post of Director: 2026
Number of shares in the Company held:400 shares【as of March 31, 2026】 -

Director (Outside Director)
Kaipin Kui
brief personal recordDirector (Outside Director)
Kaipin KuiAugust 28, 1984

Director (Outside Director)
Kaipin KuiAugust 28, 1984
2012 Joined Ping An Insurance (Group) Company of China, Ltd.
2016 Joined China Ping An Insurance Overseas (Holdings) Limited
2018 Assistant General Manager, China Ping An Insurance Overseas (Holdings) Limited
2021 Deputy General Manager, China Ping An Insurance Overseas (Holdings) Limited (incumbent)
2026 Outside Director of TSUMURA & CO. (incumbent)
Year of assumption of the post of Director: 2026
Number of shares in the Company held:0 shares【as of March 31, 2026】 -

Director and Full-Time Audit and Supervisory Committee Member
Tomihiro Nagafuchi
brief personal recordDirector and Full-Time Audit and Supervisory Committee Member
Tomihiro NagafuchiSeptember 25, 1964

Director and Full-Time Audit and Supervisory Committee Member
Tomihiro NagafuchiSeptember 25, 1964
1987 Joined the Company
2014 Head of the Internal Auditing Department, TSUMURA & CO.
2023 General Manager, TSUMURA & CO. (incumbent)
Year of assumption of the post of Director: 2023
Number of shares in the Company held:3,620 shares【as of March 31, 2026】 -

Director (Outside Director) and Audit and Supervisory Committee Member
Akemi Mochizuki
brief personal recordDirector (Outside Director) and Audit and Supervisory Committee Member
Akemi MochizukiJune 10, 1954

Director (Outside Director) and Audit and Supervisory Committee Member
Akemi MochizukiJune 10, 1954
1984 Joined Aoyama Audit Corporation
1988 Registered as certified public accountant
2018 Independent Director and Audit Committee Member of NSK Ltd. (incumbent)
2018 Partner at Akahoshi Audit Corporation
2019 Outside Director and Audit and Supervisory Committee Member of TSUMURA & CO. (incumbent)
2021 Outside Audit and Supervisory Board Member of Asahi Kasei Corporation (incumbent)
2022 Statutory Auditor (part-time) of SBI Holdings, Inc.
Year of assumption of the post of Director: 2019
Number of shares in the Company held:4,500 shares【as of March 31, 2026】 -

Director (Outside Director) and Audit and Supervisory Committee Member
Chieko Tsuchiya
brief personal recordDirector (Outside Director) and Audit and Supervisory Committee Member
Chieko TsuchiyaJanuary 27, 1971

Director (Outside Director) and Audit and Supervisory Committee Member
Chieko TsuchiyaJanuary 27, 1971
1993 Joined Citibank, N.A.
2001 Registered as an attorney at law Joined Law Offices of Hideyuki Sakai (Bingham Sakai Mimura Aizawa (foreign law joint enterprise) )
2006 Registered as an attorney in New York State
2012 Legal Officer, International Atomic Energy Agency (IAEA)
2015 Joined Anderson Mori & Tomotsune
2016 Part-time Judge of Tokyo Family Court (Domestic Relations Conciliator)
2019 Special Counsel, Anderson Mori & Tomotsune (incumbent)
2021 Consultant, Tilleke & Gibbins International Ltd. (Thailand)
2025 Outside Director, Audit and Supervisory Committee Member, MICRONICS
JAPAN CO., LTD. (incumbent)2025 Outside Director and Audit and Supervisory Committee Member of TSUMURA & CO. (incumbent)
Year of assumption of the post of Director: 2025
Number of shares in the Company held:0 shares【as of March 31, 2026】
Executive Officers (as of April 1, 2026)
| Terukazu Kato |
CEO |
|---|---|
| Kei Sugii |
COO and President, Prescription Pharmaceuticals Company |
| Kaoru Kobayashi |
CFO and Head of Corporate Management Division, Prescription Pharmaceuticals Company |
| Akihito Konda |
CTO (Chief Technology Officer) and Head of Research & Development Division, Prescription Pharmaceuticals Company |
| Li Gang |
Executive Officer President, China Business Company |
| Toshio Yamaoka |
Executive Officer Head of Pharmaceutical Sales & Marketing Division, Prescription Pharmaceuticals Company |
| Yasushi Nakagawa |
Executive Officer President, Consumer Health Company |
| Koji Shiseki |
Executive Officer Head of Corporate Secretary Division, Prescription Pharmaceuticals Company |
| Shoichi Kumagai |
Executive Officer Head of Production Division, Prescription Pharmaceuticals Company |
| Kazushige Mizoguchi |
Executive Officer Head of Quality & Safety Management Division, Prescription Pharmaceuticals Company |
| Zhang Lixian |
Executive Officer China Coordination Department, China Business Company |
| Yoshiharu Watanabe |
Executive Officer Botanical Raw Materials Division, China Business Company |